Agios Pharmaceuticals | Marketskapitalisme



Market Capitalization Endring Dato
AbbVie USD 314.02B 34.8B 2024-12
Agios Pharmaceuticals USD 1.87B 654M 2024-12
Alnylam Pharmaceuticals USD 30.35B 4.96B 2024-12
Amgen USD 140.1B 33.03B 2024-12
Arrowhead Research USD 2.34B 69M 2024-12
Astellas Pharma JPY 2.76T 250.98B 2024-12
AstraZeneca GBP 162.31B 17.34B 2024-12
Bayer EUR 29.79B 3.87B 2024-09
Biogen USD 22.28B 5.95B 2024-12
BioMarin Pharmaceutical USD 12.53B 867M 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Daiichi Sankyo JPY 8.47T 695.09B 2024-12
Eli Lilly USD 732.87B 109.15B 2024-12
Exelixis USD 9.51B 2.11B 2024-12
Gilead Sciences USD 115.12B 10.74B 2024-12
GlaxoSmithKline GBP 55.81B 7.05B 2024-12
Incyte USD 13.31B 576M 2024-12
Ionis Pharmaceuticals USD 5.52B 791M 2024-12
Merck USD 251.65B 36.21B 2024-12
Moderna USD 16B 9.69B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Novartis USD 230.87B 3.48B 2024-09
Pfizer USD 150.34B 13.65B 2024-12
Regeneron Pharmaceuticals USD 78.28B 37.61B 2024-12
Vertex Pharmaceuticals USD 103.71B 16.33B 2024-12



Agios Pharmaceuticals Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.